Gland Pharma Limited (NSE: GLAND) reports record revenues for Q1 FY27, with a 20% Y-o-Y growth and a 47% surge in PAT.
Gland Pharma Limited (NSE: GLAND) announces strategic CDMO partnership with a leading global pharmaceutical company for sterile injectable products.
Gland Pharma Limited (GLAND) announces strategic collaboration with Neuland Laboratories to expand sterile API manufacturing through a new cGMP suite.
Gland Pharma Limited (GLAND) receives USFDA approval for Sugammadex Injection 200 mg/2 mL, expanding its injectable portfolio.
Gland Pharma Limited (NSE: GLAND) stock price dropped 5% intraday to ₹2353.7, breaking below support in the Healthcare sector.
Gland Pharma Limited (NSE: GLAND) moves up 5% intraday to ₹2502.1, testing resistance in the healthcare sector. Check the latest trend..
Gland Pharma Limited (NSE: GLAND) reports record revenues and profitability with 22% YoY growth in Q4 FY26 and 97% PAT growth.